Oligonucleotide therapeutics hold strong potential, but taking them from design to production involves complex hurdles. Impurities, sequence confirmation, purification, and compliance can all affect quality. Rigorous characterization and careful process control are essential to ensure the safety, efficacy, and scalability of these advanced therapies.
Download this ebook to learn:
- Key challenges in oligonucleotide synthesis, from impurities to scaling
- Analytical strategies for purity, sequence, and impurity checks
- Tips for scaling up purification and production
